European Commission logo
English English
CORDIS - EU research results
CORDIS

Article Category

News
Content archived on 2023-03-09

Article available in the following languages:

EU-funded researchers use yeast to help piece together human genome sequence jigsaw

Using yeast as a model, a team of Spanish researchers has made predictions about how individuals differ from one another by analysing genome sequences. Their study received a European Research Council (ERC) Starting Grant worth EUR 1.1 million under the EU's Seventh Framework ...

Using yeast as a model, a team of Spanish researchers has made predictions about how individuals differ from one another by analysing genome sequences. Their study received a European Research Council (ERC) Starting Grant worth EUR 1.1 million under the EU's Seventh Framework Programme (FP7). Writing in the journal Nature Genetics, the researchers emphasise that their findings have important implications for the future of personalised medicine. If scientists can better understand which genes are important to a particular process, it is easier to make accurate predictions about an individual's biological make-up. We are all made up of over 20,000 genes, and in each of us, several thousand of these genes carry mutations. Scientists don't yet know what happens when most human genes are altered, which means they can't yet make any predictions about human health based on genome sequence. In practice, this means that for most common human diseases, which genes are important is something that remains unknown. Consequently, a scientist can't tell whether an individual will develop a condition based on his or her DNA sequence. To confront this problem head on and assess whether it is possible to make useful predictions about the biology of individuals, the Spanish researchers carried out tests on budding yeast, a species commonly studied as a 'model organism' by researchers the world over. 'The key point is that in a model organism, we can test how good our predictions are. We have a much better idea of the genes that are important for each process, and so we can really test whether we can make useful predictions about the biology of individuals, such as whether they are affected by a drug,' says one of the study authors, Ben Lehner from the Centre for Genomic Regulation (CRG) in Barcelona, Spain. 'In yeast we can make predictions, and then we can use a large number of fast and cheap experiments to test whether these predictions are correct. This is very important - to be able to experimentally test how well prediction methods actually work.' The team evaluated predictions about the phenotypes of 19 varieties of yeast. The first challenge the Spanish researchers faced was determining which of the approximately 3,000 mutated genes in each organism are actually altered. They then needed to predict whether each individual was likely to be abnormal for a particular phenotype such as growth in a different environmental condition. The study results show that there are at least two necessary conditions for such predictions to be made: good knowledge about which genes are important for a phenotype, and experiments performed on individuals under controlled conditions to evaluate how accurate the predictions are. As this remains tricky in humans due to the many different variables involved, and the fact that most genes that affect particular phenotypes and diseases remain unidentified, the team stress the importance of carrying out further studies on simple model organisms like budding yeast. 'The most important thing is to have comprehensive knowledge about the genes that are important for a particular phenotype. It is not possible to predict accurately if we only know a subset of the genes that are important,' says another study author, Rob Jelier, also from the CRG. 'However, we found that, when our understanding of gene function is good, quite accurate predictions can be made using a surprisingly simple genetic model. This provides some hope for the future of personalised and predictive medicine in humans.'For more information, please visit:European Molecular Biology Laboratory - Centre for Genomic Regulation (EMBL-CRG):http://pasteur.crg.es/portal/page/portal/Internet/

Countries

Spain